Cited by 131Probiotics and Fermented FoodsGut microbiota and healthMicrobial Metabolites in Food Biotechnology

Effect of probiotic and synbiotic supplementation on inflammatory markers in health and disease status: A systematic review and meta-analysis of clinical trials

Kazemi, Asma, Soltani, Sepideh, Ghorabi, Sima, Keshtkar, Abbas, Daneshzad, Elnaz, Nasri, Fatemeh, Mazloomi, Seyed Mohammad·2020·Clinical Nutrition

Abstract

The current systematic review and meta-analysis investigated the effect of probiotic/synbiotic on a wide range of inflammatory and anti-inflammatory markers in healthy and various disease conditions. PubMed, SCOPUS and Web of Science databases were searched. All clinical trials which investigated the effect of oral administration of probiotic or synbiotic on inflammatory markers (C-reactive protein (CRP), interleukin (IL) 1β, IL-4, IL-6, IL-8, IL-10, IL-12, tumor necrosis factor (TNF) α, interferon (IFN) γ and transforming growth factor (TGF) β) for more than one week with concurrent control groups were included. One-hundred sixty seven publications was analysed. Results were as follows: CRP decreased in healthy, metabolic disorders, inflammatory bowel disease (IBD), arthritis and critically ill condition but not in renal failure. IL-1B: no change in healthy subjects and arthritis. TNF-α: decreased in healthy, fatty liver, IBD and hepatic cirrhosis, no change in diabetes, metabolic syndrome (MS) + PCOS (polycystic ovary syndrome) and arthritis. IL-6: no change in healthy, metabolic disorders and arthritis, increased in cirrhosis and renal failure, decreased in PCOS + MS. IL-10: no change in healthy, IBD and metabolic disorders, increased in arthritis. IL-4, IL-8, IL-12, IFN-g and TGF-b: no change in healthy subjects. In conclusion, probiotic/synbiotic decreased some of the inflammatory markers. The intervention was most effective in CRP and TNF-α reduction in healthy or disease state. Moreover, the intervention decreased inflammation most effectively in the following disease conditions, respectively: IBD, arthritis, fatty liver. PROSPERO REGISTRATION NUMBER: CRD42018088688.

Integrity signals

Registry

Crossref · 10.1016/j.clnu.2019.04.004

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Numerous studies have shown that dietary modification, or treatment with probiotics or synbiotics, has the potential to restore normal insulin function.

    “Numerous studies have shown that dietary modification [168,169,170], or treatment with probiotics or synbiotics, has the potential to restore normal insulin function [57,171].”

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kazemi, A., Soltani, S., Ghorabi, S., Keshtkar, A., Daneshzad, E., Nasri, F., & Mazloomi, S. M.
Affiliations
  • Shiraz University (IR)
  • Iran University of Medical Sciences (IR)
  • Tehran University of Medical Sciences (IR)
  • Shiraz University of Medical Sciences (IR)
Corresponding author
Mazloomi, Seyed Mohammad
Venue
Clinical Nutrition
Publisher
Elsevier BV
Published
2020-03
Volume
39
Issue
3
Pages
789-819
ISSN
0261-5614 (ISSN-L)
OpenAlex
W2940410648
Cited by
131
References
28
Citations by year
2026: 8 · 2025: 18 · 2024: 17 · 2023: 23 · 2022: 27 · 2021: 23 · 2020: 12 · 2019: 2
FWCI
1.44
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Funders
Shiraz University of Medical Sciences
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
Keywords
probiotics, synbiotics, inflammatory markers, C-reactive protein, TNF-α, interleukin-6, IL-10, anti-inflammatory activity, inflammatory bowel disease, arthritis, hepatic steatosis, metabolic syndrome, polycystic ovary syndrome, liver cirrhosis, renal failure, critically ill patients
MeSH terms
Health Status, Humans, Inflammation, Dietary Supplements, Probiotics, Synbiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review